Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pegaptanib sodium, an RNA aptamer specifically targeting vascular endothelial growth factor (VEGF)-165, holds great promise for investigating neovascular age-related macular degeneration (AMD).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder | |
10 mg | Inquiry | Backorder |
Description | Pegaptanib sodium, an RNA aptamer specifically targeting vascular endothelial growth factor (VEGF)-165, holds great promise for investigating neovascular age-related macular degeneration (AMD). |
In vitro | Pegaptanib impedes the VEGF165-induced phosphorylation of VEGFR2 and phospholipase Cγ, and also obstructs VEGF165-triggered calcium mobilization in human umbilical vein endothelial cells[1]. |
Cas No. | 222716-86-1 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.